Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)

SHE:300942 Revenue

Shenzhen Bioeasy Biotechnology had revenue of 70.72M CNY in the quarter ending June 30, 2026, with 17.98% growth. This brings the company's revenue in the last twelve months to 282.31M, up 22.80% year-over-year. In the year 2025, Shenzhen Bioeasy Biotechnology had annual revenue of 263.23M with 17.38% growth.

• Revenue (ttm): 282.31M
• Revenue Growth: +22.80%
• P/S Ratio: 9.48
• Revenue / Employee: 520.86K
• Employees: 542
• Market Cap: 2.68B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	263.23M	38.98M	17.38%
Dec 31, 2024	224.25M	-29.86M	-11.75%
Dec 31, 2023	254.11M	-432.79M	-63.01%
Jan 1, 2023	686.90M	89.36M	14.95%
Jan 1, 2022	597.54M	339.08M	131.20%

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 23, 2026

Data Sources Report a data error